My point being, it has now changed to no end date. I know what he said at the webinar but now in black and white the company won’t commit to a date. Déjà vu? Hernia and breast cancer went down path before. Hope I am wrong coz I thought DFU trial would be a breeze as it has already being used by surgeons in patients in Australia. albeit according to SA health, they used it an adapted version of BTM and not Syntrel.
anyone with insights?
My point being, it has now changed to no end date. I know what...
-
- There are more pages in this discussion • 1,945 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |